In addition, apigenin decreased levels of malondialdehyde, IL-1β and IL-6 as well as expression of iNOS in the colon of HFD mice, preventing enteric inflammation and normalizing colonic dysmotility associated with obesity (Gentile et al., 2018[40]). The gene discussed is IL1B; the disease is obesity disorder.